Total planned funding: $708,371,464
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Namibia | $708,371,464 |
Organizational Types
| NGO | $195,798,365 |
| Private Contractor | $138,062,012 |
| Host Country Government Agency | $114,529,879 |
| Own Agency | $90,439,673 |
| Unknown | $69,777,432 |
| University | $56,189,854 |
| Parastatal | $14,965,055 |
| Implementing Agency | $9,314,795 |
| Other USG Agency | $9,306,279 |
| FBO | $5,701,683 |
| Multi-lateral Agency | $4,286,437 |
Program Areas
| Treatment | $187,382,402 |
| Prevention | $148,963,638 |
| Care | $138,006,835 |
| Governance and Systems | $110,392,175 |
| Management and Operations | $70,685,663 |
| Testing | $52,940,751 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $153,719,995 |
| HVMS: Management and Operations | $70,685,663 |
| HKID: Care: Orphans and Vulnerable Children | $61,510,742 |
| HVCT: Testing: HIV Testing and Counseling | $52,940,751 |
| OHSS: Health Systems Strengthening | $52,627,708 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $45,221,540 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $45,220,922 |
| HBHC: Care: Adult Care and Support | $44,666,855 |
| HVSI: Strategic Information | $43,741,419 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $29,672,439 |
| HTXD: Treatment: ARV Drugs | $22,896,615 |
| HVTB: Care: TB/HIV | $21,776,972 |
| HLAB: Laboratory Infrastructure | $14,023,048 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $13,386,348 |
| PDTX: Treatment: Pediatric Treatment | $10,765,792 |
| PDCS: Care: Pediatric Care and Support | $10,052,266 |
| HMBL: Biomedical Prevention: Blood Safety | $9,747,895 |
| HMIN: Biomedical Prevention: Injection Safety | $5,714,494 |
Top Partner Programs
Potentia Namibia:
$76,341,679
Countries/Regions
USG Aggregated Agencies:
$60,135,063
Countries/Regions
Not Available:
$59,289,909
Countries/Regions